What's in Ferring Pharmaceuticals's pipeline?

Ferring Pharmaceuticals has 15 drugs in our index: 8 marketed, 0 filed, 2 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Ferring Pharmaceuticals's portfolio?

Top competitors by shared drug class: Allergan, City of Hope Medical Center, Novartis, Salah Awad Alanazi, University of Oklahoma.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/ferring-pharmaceuticals.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-14 · How we verify

Ferring Pharmaceuticals — Portfolio Competitive Intelligence Brief

Ferring Pharmaceuticals pipeline: 8 marketed, 0 filed, 2 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

8 marketed 0 filed 2 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Area
Primary nocturnal enuresis	Primary nocturnal enuresis	marketed
MINIRIN Oral Lyophilisate	MINIRIN Oral Lyophilisate	marketed
Crinone	Crinone	marketed		Other
PICOPREP	PICOPREP	marketed		Other
REBYOTA™	REBYOTA™	marketed		Other
Choriongonadotropin	Choriongonadotropin	marketed		Other
Glycerine	Glycerine	marketed	Non-Standardized Chemical Allergen [EPC]	Metabolic
Menotrophin	Menotrophin	marketed		Other
Recombinant Human Follitropin Alfa	Recombinant Human Follitropin Alfa	phase 3
FE 999326	FE 999326	phase 3

Therapeutic area mix

Other · 10
Metabolic · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Allergan · 1 shared drug class
City of Hope Medical Center · 1 shared drug class
Novartis · 1 shared drug class
Salah Awad Alanazi · 1 shared drug class
University of Oklahoma · 1 shared drug class
WU XI ZHONG ZHI WEI NA TECHNOLOGY CO., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Ferring Pharmaceuticals:

Cite this brief

Drug Landscape (2026). Ferring Pharmaceuticals — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/ferring-pharmaceuticals. Accessed 2026-05-14.